206 related articles for article (PubMed ID: 10719546)
21. Familial hypercholesterolemia: current treatment and advances in management.
Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
[TBL] [Abstract][Full Text] [Related]
22. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.
Mabuchi H; Higashikata T; Kawashiri MA
Transfus Apher Sci; 2004 Jun; 30(3):233-43. PubMed ID: 15172629
[TBL] [Abstract][Full Text] [Related]
23. [Lipid control in diabetic patients in Extremadura (Spain)].
Roberto Robles N; Barroso S; Marcos G; Sánchez Muñoz-Torrero JF;
Endocrinol Nutr; 2009 Mar; 56(3):112-7. PubMed ID: 19627723
[TBL] [Abstract][Full Text] [Related]
24. [Prevalence and treatment of hypercholesterolemia in patients with manifest vascular disease according to practice guidelines of the current cholesterol consensus].
van de Laak MF; van der Graaf Y; Banga JD; Simons PC; Algra A
Ned Tijdschr Geneeskd; 2000 Apr; 144(15):706-9. PubMed ID: 10778719
[TBL] [Abstract][Full Text] [Related]
25. [Achievement of the therapeutic goals for dyslipidemia in clinical practice: results of a survey among general practice physicians from Lombardy].
Tragni E; Catapano AL; Bertelli A; Poli A
Ital Heart J; 2003 Dec; 4 Suppl 7():47S-57S. PubMed ID: 14983746
[TBL] [Abstract][Full Text] [Related]
26. [Hyperlipidemia: therapeutic principles in clinical practice].
Müller-Wieland D; Krone W
Med Klin (Munich); 2003 Dec; 98(12):739-43. PubMed ID: 14685674
[TBL] [Abstract][Full Text] [Related]
27. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
28. Risk of myocardial infarction attributable to elevated levels of total cholesterol among hypertensives.
Glazer NL; Smith NL; Heckbert SR; Doggen CJ; Lemaitre RN; Psaty BM
Am J Hypertens; 2005 Jun; 18(6):759-66. PubMed ID: 15925732
[TBL] [Abstract][Full Text] [Related]
29. [Cholesterol: blood levels or total risk as a guide to preventive treatment?].
Mathes P
Z Kardiol; 2004; 93 Suppl 2():II16-20. PubMed ID: 15021991
[TBL] [Abstract][Full Text] [Related]
30. High blood cholesterol.
National Heart, Lung and Blood Institute
Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
[TBL] [Abstract][Full Text] [Related]
31. Cholesterol: precursor to many lipid disorders.
Jones PH
Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
[TBL] [Abstract][Full Text] [Related]
32. Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitations.
Brewer HB
Am J Manag Care; 2002 Feb; 8(2 Suppl):S23-8; discussion S45-7. PubMed ID: 11855698
[TBL] [Abstract][Full Text] [Related]
33. [Broader indication for treatment with statins; the 'heart protection study'].
Stalenhoef AF; Stuyt PM
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1921-3. PubMed ID: 12404905
[TBL] [Abstract][Full Text] [Related]
34. Heart lines. Revised cholesterol guidelines.
Harv Heart Lett; 2001 Jul; 11(11):6-7. PubMed ID: 11512536
[No Abstract] [Full Text] [Related]
35. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
Capriotti T
Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
[No Abstract] [Full Text] [Related]
36. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
[TBL] [Abstract][Full Text] [Related]
37. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
[TBL] [Abstract][Full Text] [Related]
38. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
[TBL] [Abstract][Full Text] [Related]
39. [The Dutch National Colesterol Test: participants mainly healthy].
Deutekom M; Aziz Y; van Dis I; Stronks K; Bossuyt PM
Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2425-9. PubMed ID: 19055144
[TBL] [Abstract][Full Text] [Related]
40. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration.
Blanco-Colio LM; Martín-Ventura JL; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Martineau P; Egido J;
Am Heart J; 2007 May; 153(5):881-8. PubMed ID: 17452168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
